Matrine ameliorates spontaneously developed colitis in interleukin-10-deficient mice
Matrine ameliorates spontaneously developed colitis in interleukin-10-deficient mice
复制标题
DOI:
10.1016/j.intimp.2016.04.038
复制
发表时间:
2016-07-01
影响因子:
5.6
通讯作者:
Huang, Kehe
中科院分区:
文献类型:
--
作者:
Wu, Cong;Xu, Zheng;Huang, Kehe
Interleukin-10 (IL-10)-deficient mice spontaneously develop T cell-mediated colitis. Previous reports have shown that Matrine may reduce the symptoms of acute colitis induced by trinitrobenzene sulfonic acid (TNBS). However, whether Matrine impacts chronic colitis remains unknown. In this study, we investigated whether Matrine could limit the symptoms of spontaneously developed colitis and its potential molecular mechanisms. IL-10 deficient mice were given Matrine or a PBS control by oral gavage daily for 4 weeks and were euthanized at week 2 or week 4. We measured body weight, colon length and weight, and histological scores. We also evaluated the spontaneous secretion of IL-12/23p40, IFN-gamma and IL-17 in colon explant cultures As well as IFN-gamma and IL-17 secretion in unseparated mesenteric lymph node (MLN) cells, and assessed IFN-gamma, IL-17, IL-1 beta and IL-6 mRNA expression in colon tissue. In addition, we analyzed the proportions of CD4-positive and CD8-positive cells in unseparated MLN cells. Our results show that Matrine-treated mice exhibited better body weight recovery than controls and that histological scores and spontaneously secreted IL-12/23p40, IFN-gamma and IL-17 in colon tissue were significantly decreased in treated mice compared with controls. The proportion of CD4-positive cells of MLNs in treated mice was significantly smaller than that in controls at week 4. Both cytokine production and mRNA expression of IFN-gamma and IL-17 were significantly reduced in treated mice compared with controls. Taken together, our results indicate that Matrine may ameliorate spontaneously developed chronic colitis and could be considered as a therapeutic alternative for chronic colitis. (C) 2016 Elsevier B.V. All rights reserved.